TABLE 3.
Population REID [Radiation-Induced Deaths/Gy (×102)] for a Population Having the Mortality Rates of the 2017 UK Population Based on Model Coefficients Derived from Maximum Likelihood Fits Using Either (a) Unadjusted Doses, (b) Adjusted Truncated. Doses, (c) Regression Calibration adjusted Doses or (d) MCMC Mean Doses (from the Stage 1 Models)
| Mortality end point | Test dose (Gy) |
||||||
|---|---|---|---|---|---|---|---|
| Relative rate models |
Absolute rate models |
||||||
| 0.01 | 0.1 | 1 | 0.01 | 0.1 | 1 | ||
| Solid cancer | Unadjusted dose | 4.31 | 4.49 | 6.06 | 3.80 | 4.11 | 6.83 |
| Adjusted, truncated dosea | 3.70 | 4.01 | 6.68 | 2.84 | 3.33 | 7.66 | |
| Regression calibration adjusted | 3.96 | 4.19 | 6.16 | 3.22 | 3.59 | 6.90 | |
| MCMC dose means | 3.83 | 4.13 | 6.81 | 2.97 | 3.46 | 7.80 | |
| Lung cancer | Unadjusted dose | 2.81 | 2.82 | 2.93 | 1.93 | 1.98 | 2.41 |
| Adjusted, truncated dosea | 2.81 | 2.85 | 3.15 | 1.79 | 1.87 | 2.61 | |
| Regression calibration adjusted | 2.87 | 2.88 | 3.06 | 1.84 | 1.90 | 2.44 | |
| MCMC dose means | 2.89 | 2.92 | 3.23 | 1.83 | 1.92 | 2.67 | |
| Stomach cancer | Unadjusted dose | 0.10 | 0.10 | 0.11 | 0.82 | 0.84 | 1.01 |
| Adjusted, truncated dosea | 0.10 | 0.10 | 0.12 | 0.76 | 0.79 | 1.12 | |
| Regression calibration adjusted | 0.10 | 0.10 | 0.11 | 0.76 | 0.78 | 1.05 | |
| MCMC dose means | 0.10 | 0.10 | 0.12 | 0.73 | 0.77 | 1.19 | |
| Breast cancer | Unadjusted dose | 2.16 | 2.13 | 1.85 | 0.97 | 0.96 | 0.86 |
| Adjusted, truncated dosea | 2.20 | 2.17 | 1.92 | 0.99 | 0.98 | 0.89 | |
| Regression calibration adjusted | 2.20 | 2.17 | 1.91 | 0.99 | 0.98 | 0.88 | |
| MCMC dose means | 2.18 | 2.15 | 1.93 | 0.98 | 0.97 | 0.90 | |
| All solid cancer apart from lung, stomach breast | Unadjusted dose | 0.58 | 0.76 | 2.51 | −0.07 | 0.22 | 2.99 |
| Adjusted, truncated dosea | 0.07 | 0.34 | 2.90 | −0.09 | 0.20 | 3.02 | |
| Regression calibration adjusted | 0.28 | 0.49 | 2.47 | −0.10 | 0.19 | 2.99 | |
| MCMC dose means | 0.15 | 0.42 | 2.97 | −0.10 | 0.19 | 3.04 | |
| Leukemia excluding CLL | Unadjusted dose | 0.38 | 0.43 | 0.91 | 0.42 | 0.46 | 0.93 |
| Adjusted, truncated dosea | 0.24 | 0.31 | 1.03 | 0.29 | 0.36 | 1.06 | |
| Regression calibration adjusted | 0.27 | 0.33 | 0.90 | 0.33 | 0.38 | 0.93 | |
| MCMC dose means | 0.24 | 0.32 | 1.05 | 0.30 | 0.37 | 1.07 | |
| Circulatory disease | Unadjusted dose | 2.56 | 2.52 | 2.05 | 5.38 | 4.88 | 2.62 |
| Adjusted, truncated dosea | 2.66 | 2.60 | 2.12 | 5.78 | 5.20 | 2.67 | |
| Regression calibration adjusted | 2.66 | 2.61 | 2.15 | 5.45 | 4.95 | 2.72 | |
| MCMC dose means | 2.49 | 2.45 | 2.11 | 5.82 | 5.24 | 2.68 | |
a
Adjusted, truncated dose as supplied by RERF with the collapsed person-year table.